Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.23 | 3e-06 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-05 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.32 | 8e-05 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0005 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |